Alex Wesselhoeft

Alex is a Founder, former Board Director, and Director of Molecular Biology at Orna where he leads the development of Orna’s synthetic circular RNA (oRNA) platform. An inventor, scientist, and entrepreneur, he earned his Ph.D. from the Massachusetts Institute of Technology, where he created the first effective oRNAs that would become Orna’s foundational technology. His work led to two key publications that substantiated the field of synthetic circular RNA and enabled their use for investigative therapeutic applications. Alex co-founded Orna with Raffaella Squilloni to develop oRNA into the next generation of long RNA therapeutics. Earlier in his career, Alex worked in the laboratory of Tyler Jacks at the Massachusetts Institute of Technology to study the contribution of stem cells to tumor growth. He obtained his B.S. from the University of Massachusetts, Amherst, where he investigated gamma-delta T cell function.

Alex Wesselhoeft is the Founder & Director, Molecular Biology at Orna Therapeutics, based in United States, North America. With a background in Biotechnology, Alex Wesselhoeft has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.